Medeon Biodesign

Medeon Biodesign FCF per Share

The Free Cash Flow per Share of Medeon Biodesign (6499.TWO) as of Nov 6, 2026 is -6.66 TWD. In the previous year, Free Cash Flow per Share was -9.85 TWD — a change of -32.33% (higher).

FCF per Share

-6.66TWD

YoY

-32.33%

Last updated:

Free Cash Flow per Share of Medeon Biodesign is 2025 -6.66 TWD. Free Cash Flow per Share of Medeon Biodesign was 2024 -9.85 TWD. It decreases by -32.33% higher compared to the previous year.

The Medeon Biodesign FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2018
4.29 TWD
Jan 1, 2019
-3.98 TWD
Jan 1, 2020
-2.36 TWD
Jan 1, 2021
-4.14 TWD
Jan 1, 2022
-6.87 TWD
Jan 1, 2023
-8.83 TWD
Jan 1, 2024
-9.85 TWD
Jan 1, 2025
-6.66 TWD
The Medeon Biodesign FCF per Share history
YEARFCF per ShareYoY
-6.66TWD-32.33%
-9.85TWD+11.53%
-8.83TWD+28.56%
-6.87TWD+66.01%
-4.14TWD+75.50%
-2.36TWD-40.72%
-3.98TWD-192.60%
4.29TWD-158.88%
-7.29TWD+162.14%
-2.78TWD+16.31%
-2.39TWD+81.23%
-1.32TWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Medeon Biodesign Stock analysis

What does Medeon Biodesign do? Medeon Biodesign Inc, headquartered in Taipei City, Taiwan, develops, manufactures, and sells medical equipment. Listed on 11 December 2014, the company specializes in medical apparatus and instruments for laparoscopic and cardiac catheter minimally invasive surgeries. Its products are distributed domestically and internationally, serving the Health Care sector with innovative surgical solutions. Medeon Biodesign is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medeon Biodesign stock

Free Cash Flow per Share of Medeon Biodesign is -6.66 TWD in 2025.

Free Cash Flow per Share of Medeon Biodesign changed from -9.85 TWD to -6.66 TWD, representing a -32.33% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share Medeon Biodesign since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Medeon Biodesign

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Medeon Biodesign